Covered recipient · General Payments record
JESSICA C BAITY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$8,416.18
- Reported across 354 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $540.28 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurelis, Inc. | $116.97 | 4 |
| Neurocrine BioSciences, Inc. | $105.70 | 4 |
| UCB, Inc. | $79.40 | 4 |
| Amgen Inc. | $63.46 | 3 |
| ABBVIE INC. | $60.17 | 3 |
| ACADIA Pharmaceuticals Inc | $45.43 | 2 |
| PFIZER INC. | $33.37 | 2 |
| Celgene Corporation | $21.34 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.76 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103266445 | CMS |
| ABBVIE INC. | $30.01 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103266447 | CMS |
| ABBVIE INC. | $16.40 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103266449 | CMS |
| ACADIA Pharmaceuticals Inc | $30.21 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147962671 | CMS |
| ACADIA Pharmaceuticals Inc | $15.22 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147962673 | CMS |
| Amgen Inc. | $16.09 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522863 | CMS |
| Amgen Inc. | $21.76 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522865 | CMS |
| Amgen Inc. | $25.61 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522867 | CMS |
| Celgene Corporation | $21.34 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101145831 | CMS |
| Neurelis, Inc. | $36.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632684 | CMS |
| Neurelis, Inc. | $27.93 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632688 | CMS |
| Neurelis, Inc. | $22.02 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632692 | CMS |
| Neurelis, Inc. | $30.91 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632696 | CMS |
| Neurocrine Biosciences, Inc. | $26.24 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150836144 | CMS |
| Neurocrine Biosciences, Inc. | $19.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150859371 | CMS |
| Neurocrine Biosciences, Inc. | $34.64 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150819290 | CMS |
| Neurocrine Biosciences, Inc. | $24.93 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150840116 | CMS |
| PFIZER INC. | $15.08 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131363621 | CMS |
| PFIZER INC. | $18.29 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131065179 | CMS |
| UCB, Inc. | $18.21 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143044249 | CMS |
| UCB, Inc. | $15.04 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143044251 | CMS |
| UCB, Inc. | $14.15 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143044253 | CMS |
| UCB, Inc. | $32.00 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143044255 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.44 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598728 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.